Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2020.06.013
Abstract: Receptor Interacting Protein 2 (RIP2) kinase inhibitors have been reported for therapeutic opportunities in inflammatory bowel diseases such as Ulcerative Colitis and Crohn's disease. During lead optimization, team identified 4-aminoquinoline series and several compounds from…
read more here.
Keywords:
permeability high;
high glycoprotein;
efflux ratio;
glycoprotein efflux ... See more keywords